Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study (original) (raw)

Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine

Durk Wiersma

Journal of Psychopharmacology, 2012

View PDFchevron_right

The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study

Dick Veltman

Journal of Psychopharmacology, 2014

View PDFchevron_right

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

Suzannah Zimmet

Schizophrenia Research, 2003

View PDFchevron_right

Cannabis cue-induced brain activation correlates with drug craving in limbic and visual salience regions: Preliminary results

Maciej Buchowski

Psychiatry Research: Neuroimaging, 2013

View PDFchevron_right

Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity

Nikolaos Kelekis

npj Schizophrenia

View PDFchevron_right

Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse

abi hasan

2009

View PDFchevron_right

Cue Reactivity in the Ventral Striatum Characterizes Heavy Cannabis Use, Whereas Reactivity in the Dorsal Striatum Mediates Dependent Use

Keith Kendrick

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2019

View PDFchevron_right

Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects

Nadia Solowij

Journal of Psychopharmacology, 2004

View PDFchevron_right

Clozapine decreases [3H] CP 55940 binding to the cannabinoid1 receptor in the rat nucleus accumbens

S. Sundram

Naunyn-Schmiedeberg's Archives of Pharmacology, 2005

View PDFchevron_right

Interaction of Cannabis Use Disorder and Striatal Connectivity in Antipsychotic Treatment Response

Christina Fales

Schizophrenia Bulletin Open, 2020

View PDFchevron_right

Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine

Svetlana Semenova

Biological Psychiatry, 2003

View PDFchevron_right

An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use

Jan Berle

Frontiers in Psychiatry, 2012

View PDFchevron_right

Neurobiology of Comorbid Substance Use Disorders in Mental Illness: A Closer Look at the Underlying Commonalities between Cannabis and Schizophrenia

Rishab Gupta

Current Addiction Reports, 2014

View PDFchevron_right

Marijuana craving in the brain

Ursula Myers

Proceedings of the National Academy of Sciences of the United States of America, 2009

View PDFchevron_right

Cannabinoid Receptor Antagonists Counteract Sensorimotor Gating Deficits in the Phencyclidine Model of Psychosis

Michele ZOLI

Neuropsychopharmacology, 2007

View PDFchevron_right

Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency

Zoltan Makkos, Lilla Fejes

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011

View PDFchevron_right

The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues

Michael Perdices

Australian and New Zealand Journal of Psychiatry, 2007

View PDFchevron_right

Lev-Ran 2012- Neurocognitive functions of heavy cannabis using schizophrenia patients

Yoram Braw

View PDFchevron_right

Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder

Mark Greenwald

Drug and Alcohol Dependence, 2016

View PDFchevron_right

Craving in Patients with Schizophrenia and Cannabis Use Disorders

Thomas Schnell

The Canadian Journal of Psychiatry, 2013

View PDFchevron_right

Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis

Krzysztof Krysta

Medical Science Monitor, 2012

View PDFchevron_right

Biological aspects of cannabis consumption in schizophrenia

dan madalina

Archives of Biological Sciences, 2014

View PDFchevron_right

Variable individual sensitivity to cannabis in patients with schizophrenia

David Gourion

International Journal of Neuropsychopharmacology, 2010

View PDFchevron_right

Neurocognitive functions of heavy cannabis using schizophrenia patients

Yoram Braw

European Psychiatry

View PDFchevron_right

Cannabis and cue-induced craving in cocaine-dependent individuals: A pilot study

Maykel Ghabrash

Addictive Behaviors, 2017

View PDFchevron_right

Cannabinoids and vanilloids in schizophrenia: Neurophysiological evidence and directions for basic research

Lezio S Bueno-Junior

Frontiers in Pharmacology, 2017

View PDFchevron_right

Cannabis, cannabinoids and schizophrenia: integration of the evidence

Vaughan Carr

Australian and New Zealand Journal of Psychiatry, 2008

View PDFchevron_right

Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers

Stefan Borgwardt

2012

View PDFchevron_right

Induction of psychosis byδ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing

Stefan Borgwardt

View PDFchevron_right